Stay updated with breaking news from Ronald Silver. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Tuesday. Several other brokerages have also recently issued reports on IRWD. TheStreet raised Ironwood Pharmaceuticals from a “c” rating to a “b-” rating in a report on Wednesday, January 19th. Piper […]
Equities research analysts at Piper Sandler initiated coverage on shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) in a research note issued to investors on Friday, The Fly reports. The firm set an “overweight” rating on the biotechnology company’s stock. Several other research firms also recently weighed in on IRWD. StockNews.com raised Ironwood Pharmaceuticals from […]
Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) have been assigned a consensus recommendation of “Buy” from the six ratings firms that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year […]
Wall Street analysts expect that Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) will post $97.13 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Ironwood Pharmaceuticals’ earnings. The lowest sales estimate is $97.00 million and the highest is $97.26 million. Ironwood Pharmaceuticals posted sales of $88.85 million […]
Wall Street brokerages expect Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) to report earnings per share of $0.31 for the current quarter, according to Zacks. Two analysts have made estimates for Ironwood Pharmaceuticals’ earnings. The highest EPS estimate is $0.36 and the lowest is $0.27. Ironwood Pharmaceuticals posted earnings of $0.24 per share in the […]